Fatigue linked to COPD severity, hospitalization risk

By Mark Cowen, Senior medwireNews reporter

Fatigue is associated with disease severity in patients with chronic obstructive pulmonary disease (COPD), researchers confirm.

Importantly, Johanna Paddison (Repatriation General Hospital, Adelaide, Australia) and team also found that, independent of disease severity, fatigue is a significant predictor for hospitalization risk in patients with the lung disease.

The findings come from a study of 100 patients with stable COPD who were due to start a pulmonary rehabilitation program.

The participants were assessed at study entry for "fatigue experiences" and "fatigue impacts" using the Identity-Consequences Fatigue Scale (ICFS), and for COPD severity using the BODE (body mass index, degree of airflow obstruction, dyspnea, and exercise capacity) index.

Over the 2-month follow-up period, 24% of the COPD patients were admitted to hospital at least once, of whom more than half (58%) were admitted at least twice.

Overall, there was a significant relationship between ICFS fatigue experiences and impact scores and BODE scores in the COPD patients.

Dividing the COPD patients into three groups based on fatigue experience scores, the team found that the risk for hospitalization during follow-up was 11.4-fold greater among participants in the most severely fatigued group and 5.0-fold greater among those in the middle group compared with patients in the least fatigued group.

Similarly, COPD patients in the highest third for fatigue impact scores were 13.6 times more likely to be hospitalized than those in lowest third for fatigue impact scores. However, there was no significant difference in risk for hospitalization between COPD patients in the middle group for fatigue impact scores and those in highest and lowest scoring groups.

Paddison et al conclude in the European Respiratory Journal: "This study confirms that fatigue reports are systematically related to markers of COPD disease severity.

"Of greater clinical importance, our results show that, independent of disease severity, fatigue is a strong predictor of hospitalisation risk, which is itself an important driver of impaired quality of life, negative impact on self and family, escalation of personal and societal costs, and ongoing instability and mortality."

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Medical and behavioral interventions can reduce fatigue in people with multiple sclerosis